A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity
The FDA recently approved a new use for Wegovy (semaglutide), the blockbuster anti-obesity drug, to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are…